Filters

Latest News

2022-06-21 09:39:33

Global pharmaceutical industry leaders meet with German officials to discuss life sciences innovation in Germany and global pandemic response involving the G7

Berlin, 21 June, 2022 – Today, global leaders from the pharmaceutical industry met with German officials from the ministries of ...

Read More

2022-06-17 07:12:58

Pharmaceutical industry expresses deep disappointment with decision on waiving intellectual property rights adopted at the World Trade Organization Ministerial Conference

IFPMA, the body representing biopharmaceutical companies in Geneva, expresses deep disappointment with the decision taken ...

Read More

2022-05-23 08:17:57

Improving access to and use of essential life-saving cancer medicines in LLMICs

This news release was originally published by UICC on 20 May 2022. IFPMA and many ...

Read More

2022-05-22 23:00:57

Pharma analysis of lessons learned from COVID-19 pandemic informs and offers shared solutions to consolidate innovation successes and improve equitable access for future pandemic response

Swift pathogen surveillance and sharing, an enabling innovation ecosystem, and regulatory agility are among the ...

Read More

2022-04-26 17:00:48

Celebrating World IP Day with a focus on youth and innovation

Geneva, 26 April 2022 – On World Intellectual Property (IP) Day, the International Federation of ...

Read More

2022-04-13 12:45:21

COVID-19 vaccines and treatments output continues apace; as health systems and last mile hurdles remain collective stumbling blocks

To date, over 13 billion doses of COVID-19 vaccines have been produced and 11 billion ...

Read More

2022-04-04 13:49:50

Largest pharmaceutical industry-backed collective venture fund tackling antimicrobial resistance announces first portfolio investments

April 4, 2022, Geneva – The international trade body representing the biopharmaceutical industry (IFPMA) today ...

Read More

Latest Statement

2022-06-15 11:04:34

IFPMA’s comments on annotated outline of a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response

The biopharmaceutical industry has been at the forefront of the response to the current pandemic and, as a result, is ...

Read More

2022-06-09 08:00:45

Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12)

April 4, 2022, Geneva – The international trade body representing ...

Read More

2022-05-27 09:00:20

IFPMA and BIO Statement on Influenza Preparedness for WHA75 agenda item 17.1

April 4, 2022, Geneva – The international trade body representing ...

Read More

2022-05-25 12:00:12

IFPMA, GSCF, DITTA, and GMTA Statement on NCDs for WHA75 agenda item 14.1

April 4, 2022, Geneva – The international trade body representing ...

Read More

2022-05-24 08:09:34

IFPMA, GSCF, and DITTA Statement on Health Emergencies for WHA75 agenda item 16.2

April 4, 2022, Geneva – The international trade body representing ...

Read More

2022-05-10 16:56:42

Open Letter on ACT-A Therapeutics and Ongoing Roadblocks to Enhancing Access

April 4, 2022, Geneva – The international trade body representing ...

Read More

2022-05-10 12:25:38

IFPMA statement on Quad’s Outcome Document on TRIPS

April 4, 2022, Geneva – The international trade body representing ...

Read More

mailto:a.jones@ifpma.org

Abigail Jones - Director, Communications

Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.

mailto:m.depol@ifpma.org
Twitter @MorganePol

Morgane De Pol - Deputy Director, Communications

Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

News Release

meeting-discusses-covid-19-vaccine-manufacturing-bottlenecks-that-must-be-urgently-tackled-for-c19-vaccine-output-to-reach-its-full-potential

Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential

9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of

Read More

Our Blog

Latest Tweets

RT @ForeignPolicyPR: "In a pandemic, the utmost importance is immediate access to pathogens and genetic sequence data. That worked amazingl…
2
Today, the challenge is not getting hold of #COVID19 vaccines, rather getting them into arms. IFPMA… https://t.co/Y9Tm9rz6hm
1
How can #C19LessonsLearned shape better pandemic prep & response for the future? Join @ForeignPolicyhttps://t.co/SRUw6Rxrwe
2
We’ve seen that vaccines can do amazing things, but even more incredible is what we’ll never have to see. Vaccine i… https://t.co/HPWtKY8rXN
Every year, more than 3 million children are hospitalised with the respiratory virus #RSV. New innovations like vac… https://t.co/hdm76mDiRv
2 2